Markets:

Overview

News

Currencies

International

Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

153.32 -9.79 (-6.00%)

Streaming Delayed Price Updated: 1:28 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Baird Maintains Outperform Rating for Icon: Here's What You Need To Know ↗

May 01, 2023

Via Benzinga

Where Icon Stands With Analysts ↗

April 28, 2023

Via Benzinga

ICON Reports First Quarter 2023 Results

April 26, 2023

From ICON plc

Via Business Wire

What 5 Analyst Ratings Have To Say About Icon ↗

April 04, 2023

Via Benzinga

ICON plc Schedules First Quarter 2023 Earnings Conference Call

March 29, 2023

From ICON plc

Via Business Wire

Earnings Preview For Icon ↗

February 21, 2023

Via Benzinga

Hopeful Golden Cross Forms On Icon's Chart ↗

February 08, 2023

Via Benzinga

The Latest Analyst Ratings for Icon ↗

January 17, 2023

Via Benzinga

Where Icon Stands With Analysts ↗

November 09, 2022

Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter:

Via Benzinga

2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch ↗

March 25, 2023

These companies strive to bring down the cost of developing new therapies.

Via The Motley Fool

Should You Bring The Luck Of The Irish To Your Investmets?

March 17, 2023

An index of Irish stocks is outperforming the S&P 500 this year, with large, U.S.-listed companies such as Ryan Air and CRH among top price performers.

Via MarketBeat

Topics ETFs Stocks

Catalent Stock Showing Improved Relative Strength Rating ↗

March 10, 2023

On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74.

Via Investor's Business Daily

ICON plc to Present at Upcoming Investor Conferences

February 27, 2023

From ICON plc

Via Business Wire

Where Icon Stands With Analysts ↗

October 06, 2022

Analysts have provided the following ratings for Icon (NASDAQ:ICLR) within the last quarter:

Via Benzinga

Analyst Ratings for Icon ↗

October 06, 2022

Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter:

Via Benzinga

ICON Reports Fourth Quarter and Full Year 2022 Results

February 22, 2023

From ICON plc

Via Business Wire

The 7 Best Growth Stocks to Buy for February 2023 ↗

February 06, 2023

Some of the best growth stocks are lesser-known names that have the ability to provide tremendous long-term upside for investors.

Via InvestorPlace

ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call

January 26, 2023

From ICON plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗

January 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023 ↗

January 13, 2023

Via Benzinga

ICON Issues Financial Guidance for Full Year 2023

January 10, 2023

From ICON plc

Via Business Wire

ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From ICON plc

Via Business Wire

ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others

December 13, 2022

From ICON plc

Via Business Wire

ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference

November 23, 2022

From ICON plc

Via Business Wire

Jim Cramer Says This Stock Down 25% This Year Is 'Not To Be Touched, Because They're Doing Very Poorly' ↗

November 21, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said AST SpaceMobile Inc (NASDAQ: ASTS) is an "exciting thing, not a stock.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022 ↗

November 09, 2022

Upgrades

Via Benzinga

ICON Reports Third Quarter 2022 Results

November 02, 2022

From ICON plc

Via Business Wire

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

ICON selected by BARDA to conduct anthrax vaccine clinical trial

October 06, 2022

From ICON plc

Via Business Wire

ICON plc Schedules Third Quarter 2022 Earnings Conference Call

September 26, 2022

From ICON plc

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.